Matches in SemOpenAlex for { <https://semopenalex.org/work/W71834047> ?p ?o ?g. }
- W71834047 abstract "Sorsby fundus dystrophy (SFD) is an autosomal dominant disorder of the central retina (Sorsby et al., 1949). It is characterized by subretinal neovascularization, atrophy of the retinal pigment epithelium and the choriocapillaris. It is a progressive disorder leading ultimately to blindness. Mutations in the TIMP3 molecule have been linked to SFD (Weber et al., 1994). So far, several point mutations have been identified in the TIMP3 molecule, all localized at the C-terminal domain of the inhibitor, the majority of which result in a single unpaired cysteine residue in the mature protein. TIMP3 belongs to a family of secreted proteins comprising four members (TIMP1, -2, -3, -4). TIMP3 is ECM (extracellular matrix) bound inhibitor with a molecular mass of 24 kDa having 12 conserved Cys residues consisting of two domains which fold independently with 3 disulfide bonds in each domain. TIMP3 is a multifunctional protein involved in the inhibition of matrix metalloproteinases (MMPs) (Murphy et. al., 1994). It can block the TACE (tumour necrosis factor (TNF)-alpha converting enzyme) (or ADAM17 - a disintegrin and metalloproteinase) mediated ectodomain shedding of pro-TNF- (Amour et al., 1998), Syndecan-1 and Syndecan-4 (Fitzgerald et al., 2000), L-selectin (Borland et al., 1999), and interleukin-6 receptor (Hargreaves et al., 1998). TIMP3 is also involved in the inhibition of the ADAMTSs (a disintegrin-like and metalloproteinase with thrombospondin type 1 motif) especially ADAMTS4, ADAMTS5 (Kashiwagi et al., 2001) and ADAMTS2 (Wang et al., 2006). TIMP3 also blocks angiogenesis by binding to VEGFR2 (vascular endothelial growth factor receptor 2) (Qi et al., 2003) and also interacts with EFEMP1 (epithelial growth factor-containing fibulin-like extracellular matrix protein 1) (Klenotic et al., 2004). TIMP3 is unique among the TIMPs in that it can inhibit TACE mediated TNF- shedding. We have measured TACE activity in liver extracts from mice deficient for the TIMP3 gene using cleavage of a fluorogenic substrate and found increased TACE activity. We were also interested to analyse the influence of the SFD mutation on the inhibition of TACE activity. The S156C mutation in the C-terminal domain of TIMP3 does not lead to significant modification of the inhibitory activity towards TACE as measured in this assay. Another biological function of TIMP3 is its ability to block ADAMTS4/ADAMTS5 (aggrecanase-1, aggrecanase-2) and MMPs mediated cleavage of aggrecan (Kashiwagi et al., 2001). TIMP3 influence on Aggrecan cleavage can be monitored by so-called neoepitope antibodies – which recognize the newly created epitope after cleavage of the aggrecan by ADAMTS4/ADAMTS5 or MMPs. In a cell-based ELISA using chondrocytes it was found that cleavage activity of ADAMTS4/ADAMTS5 and MMPs towards aggrecan are not affected either in TIMP3 knock-out (KO) chondrocytes or S156C-TIMP3 knock-in (KI) chondrocytes compared to WT counterparts. It has been also demonstrated that TIMP3 is able to block angiogenesis by competing with VEGF for binding to VEGFR2 (Qi et al., 2003). We have also used recombinant proteins to analyse the antiagiogenic property of TIMP3 via its known function of competing with VEGF ligand for its receptor (VEGFR2). The results demonstrate that the S156C mutation in the TIMP3 molecule does not have a significant effect on its capacity to bind VEGFR2 compared to WT recombinant protein. As the pathomechanism of SFD is still unknown it seemed reasonable to search for new interacting partners which might help gain insight into the molecular basis of the disease. In this context, the ability of TIMP3 to bind several different types of collagens was tested. In an ELISA, recombinant TIMP3 was able to bind to five different types of collagens in a concentration dependence manner. In parallel, TIMP3 interacted with BSA and another unrelated protein (TTR), indicating that the interactions are apparently unspecific. These interactions are mediated by the C-terminal domain of TIMP3. Cysteine residues are required for the formation of disulfide bonds which stabilize the folded conformation of proteins (Raina et. al., 1997). Therefore, a free cysteine residue in the TIMP3 molecule could potentially disturb folding of the protein. To analyse this hypothesis we have performed western blotting and detected higher molecular weight complexes caused by intermolecular disulfide bonds. As fibroblasts from the S156C KI mouse were available we quantified the amount of mutant TIMP3 in heterozygous and homozygous immortalized cell lines. ELISA results showed increased amounts of the mutant protein compared to the WT in both the ECM and cells. We next tested if the accumulation of mutant protein is due to increased resistance of the misfolded protein to proteolytic degradation. TIMP3 turnover in the ECM, determined by ELISA, revealed that S156C-TIMP3 mutant does indeed have a slower turnover compared to the WT. These results indicate that the pathomechanism of SFD is not due to a loss-of-function, but rather a toxic gain-of-function caused by accumulation of misfolded mutant TIMP3 in the ECM. Therefore, it is reasonable to conclude that the oligomeric form of TIMP3 is the major cause of the SFD disorder. This would classify SFD in the category of conformational diseases specific for the neurodegenerative disorders." @default.
- W71834047 created "2016-06-24" @default.
- W71834047 creator A5043749072 @default.
- W71834047 date "2010-02-18" @default.
- W71834047 modified "2023-09-27" @default.
- W71834047 title "Mouse models targeted for the tissue inhibitor of metalloproteinases-3 (TIMP3) - molecular and functional dissection of Sorsby fundus dystrophy (SFD)" @default.
- W71834047 cites W1250804727 @default.
- W71834047 cites W135471365 @default.
- W71834047 cites W1494656326 @default.
- W71834047 cites W1497025918 @default.
- W71834047 cites W1504137704 @default.
- W71834047 cites W1530260171 @default.
- W71834047 cites W1548050975 @default.
- W71834047 cites W1553764057 @default.
- W71834047 cites W1564532449 @default.
- W71834047 cites W1602004990 @default.
- W71834047 cites W1608370300 @default.
- W71834047 cites W1664158328 @default.
- W71834047 cites W1712774648 @default.
- W71834047 cites W1743113449 @default.
- W71834047 cites W1772888667 @default.
- W71834047 cites W1775749144 @default.
- W71834047 cites W1782613870 @default.
- W71834047 cites W180812339 @default.
- W71834047 cites W1808369276 @default.
- W71834047 cites W1844728973 @default.
- W71834047 cites W1869320174 @default.
- W71834047 cites W1873199501 @default.
- W71834047 cites W1898574519 @default.
- W71834047 cites W1923091024 @default.
- W71834047 cites W1928836998 @default.
- W71834047 cites W1954929088 @default.
- W71834047 cites W1963691526 @default.
- W71834047 cites W1969179229 @default.
- W71834047 cites W1969300977 @default.
- W71834047 cites W1969498803 @default.
- W71834047 cites W1970458434 @default.
- W71834047 cites W1970512473 @default.
- W71834047 cites W1970801102 @default.
- W71834047 cites W1973342202 @default.
- W71834047 cites W1973700873 @default.
- W71834047 cites W1974165456 @default.
- W71834047 cites W1974931019 @default.
- W71834047 cites W1979390430 @default.
- W71834047 cites W1979972616 @default.
- W71834047 cites W1980157244 @default.
- W71834047 cites W1980757321 @default.
- W71834047 cites W1980825524 @default.
- W71834047 cites W1981621503 @default.
- W71834047 cites W1982246723 @default.
- W71834047 cites W1985332381 @default.
- W71834047 cites W1988146888 @default.
- W71834047 cites W1988676851 @default.
- W71834047 cites W1990509128 @default.
- W71834047 cites W1992159395 @default.
- W71834047 cites W1992694493 @default.
- W71834047 cites W1992837858 @default.
- W71834047 cites W1993834457 @default.
- W71834047 cites W1994360534 @default.
- W71834047 cites W1994469526 @default.
- W71834047 cites W1995033273 @default.
- W71834047 cites W1995217818 @default.
- W71834047 cites W1997369314 @default.
- W71834047 cites W1997522892 @default.
- W71834047 cites W2000125965 @default.
- W71834047 cites W2000292756 @default.
- W71834047 cites W2000903132 @default.
- W71834047 cites W2003217932 @default.
- W71834047 cites W2004782135 @default.
- W71834047 cites W2005287360 @default.
- W71834047 cites W2006762876 @default.
- W71834047 cites W2007202300 @default.
- W71834047 cites W2007877800 @default.
- W71834047 cites W2008236596 @default.
- W71834047 cites W2009767819 @default.
- W71834047 cites W2010027735 @default.
- W71834047 cites W2012064275 @default.
- W71834047 cites W2013981603 @default.
- W71834047 cites W2014226393 @default.
- W71834047 cites W2014388475 @default.
- W71834047 cites W2014886449 @default.
- W71834047 cites W2014963920 @default.
- W71834047 cites W2017268676 @default.
- W71834047 cites W2017878971 @default.
- W71834047 cites W2019462131 @default.
- W71834047 cites W2020544080 @default.
- W71834047 cites W2021862667 @default.
- W71834047 cites W2022799658 @default.
- W71834047 cites W2025361420 @default.
- W71834047 cites W2025667689 @default.
- W71834047 cites W2025735321 @default.
- W71834047 cites W2026551784 @default.
- W71834047 cites W2027466246 @default.
- W71834047 cites W2028216717 @default.
- W71834047 cites W2028313997 @default.
- W71834047 cites W2030246164 @default.
- W71834047 cites W2030272140 @default.
- W71834047 cites W2030402726 @default.
- W71834047 cites W2032118018 @default.
- W71834047 cites W2032541805 @default.